Pregnancy test

Pregnancy Point of Care Testing Market - Perceptible Upsurge in Demand for hCG Urine Test Kits Until 2028, Reports Fact.MR Study

Retrieved on: 
Monday, June 24, 2019
Hormones, Endocrine system, Branches of biology, Obstetrics, Peptide hormones, Sex hormones, Midwifery, Pregnancy test, Medical tests, Human chorionic gonadotropin, HCG, Point-of-care testing

At present, smartphone-based pregnancy point of care testing products are known to transpire as promising alternatives to traditional diagnostic testing practices.

Key Points: 
  • At present, smartphone-based pregnancy point of care testing products are known to transpire as promising alternatives to traditional diagnostic testing practices.
  • Based on research analysis, human chorionic gonadotrophin (hCG) urine test kits acquired close to 43% revenue share in the global pregnancy point of care testing market in 2018.
  • In 2018, pregnancy test kits managed close to half the revenue share in the pregnancy point of care testing market, and greater reliability and accuracy of hCG urine tests associated to pregnancy point of care testing is strengthening its share in the global market.
  • Readers can easily gain access to information highlighting some of the leading manufacturers from the pregnancy point of care testing market.

Pregnancy Point of Care Testing Market - Perceptible Upsurge in Demand for hCG Urine Test Kits Until 2028, Reports Fact.MR Study

Retrieved on: 
Monday, June 24, 2019
Hormones, Endocrine system, Branches of biology, Obstetrics, Peptide hormones, Sex hormones, Midwifery, Pregnancy test, Medical tests, Human chorionic gonadotropin, HCG, Point-of-care testing

At present, smartphone-based pregnancy point of care testing products are known to transpire as promising alternatives to traditional diagnostic testing practices.

Key Points: 
  • At present, smartphone-based pregnancy point of care testing products are known to transpire as promising alternatives to traditional diagnostic testing practices.
  • Based on research analysis, human chorionic gonadotrophin (hCG) urine test kits acquired close to 43% revenue share in the global pregnancy point of care testing market in 2018.
  • In 2018, pregnancy test kits managed close to half the revenue share in the pregnancy point of care testing market, and greater reliability and accuracy of hCG urine tests associated to pregnancy point of care testing is strengthening its share in the global market.
  • Readers can easily gain access to information highlighting some of the leading manufacturers from the pregnancy point of care testing market.

True Diagnostics, Inc. Receives FDA 510(k) Clearance to Market VeriClear™ Digital Test Device for Early Result Pregnancy

Retrieved on: 
Tuesday, May 28, 2019
Health, Obstetrics, Human reproduction, Articles, Midwifery, Food and Drug Administration, United States Public Health Service, Pregnancy test, Pregnancy

True's VeriClear Digital Early Result Pregnancy Test is thesuccessful result of combining the company's proprietary Test Platform (TrueDX Platform) with its growing Co-Development Partnership Program to enable and support test solutions for Point-of-Care and Self-Testing markets.

Key Points: 
  • True's VeriClear Digital Early Result Pregnancy Test is thesuccessful result of combining the company's proprietary Test Platform (TrueDX Platform) with its growing Co-Development Partnership Program to enable and support test solutions for Point-of-Care and Self-Testing markets.
  • CEO and Founder Jerry Lee announced that with the new 510(k) FDA clearance "...we are very excited to bring VeriClear's Digital Early Pregnancy Test to market.
  • The VeriClear Digital Early Result Pregnancy Test is the latest addition to the company's growing portfolio of diagnostic devices.
  • It is the third device from True's product portfolio to receive FDA clearance within the last 16 months and it follows the clearance of the VeriClear Early Result Pregnancy Test in analog format.

Global Lateral Flow Assay Market is Projected to Reach USD 8.7 Billion by 2023 from USD 6.0 Billion in 2018 Growing at a CAGR of 7.7% From 2018 to 2023

Retrieved on: 
Wednesday, November 21, 2018
Fertility medicine, Human reproduction, Medicine, Health, RTT, Midwifery, Women's health, Obstetrics, Pregnancy test, Influenza, Infertility, Fertility testing

8.2.1.2.1 Growing Prevalence of Influenza is Expected to Drive the Influenza Testing Market.

Key Points: 
  • 8.2.1.2.1 Growing Prevalence of Influenza is Expected to Drive the Influenza Testing Market.
  • 8.2.1.3.1.1 Growing Awareness About HIV POC Testing is the Major Factors Driving Market Growth.
  • 8.2.1.3.4.1 The Rising Incidence of Gonorrhea Globally is Expected to Drive the Market During the Forecast Period.
  • 8.2.3.1.1 Pregnancy Testing is Among Well-Established Application Areas for Lateral Flow Assays, Registering Slower Growth During the Forecast Period
    8.2.3.2.1 Rising Infertility Rates Across the Globe Driving the Demand for POC Fertility Testing Kits.

Pregnancy & Fertility Rapid Test Kits - Worldwide Markets to 2022, Led by Abbott, bioMerieux, Church & Dwight, Danaher and Quidel

Retrieved on: 
Thursday, November 15, 2018
Fertility, Obstetrics, Human reproduction, Health, Birth control, Midwifery, Pregnancy test, Pregnancy, Sexual reproduction

The "Global Pregnancy and Fertility Rapid Test Kits Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pregnancy and Fertility Rapid Test Kits Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
  • The Global Pregnancy and Fertility Rapid Test Kits Market is projected to grow at a CAGR of 3.52% during the period 2018-2022.
  • Further, the report states that one challenge affecting this market is the lack of efficacy of pregnancy and fertility test kits.
  • Pregnancy test kits are not 100% accurate and this factor is hindering the growth of the market.